Comparison Between Different Doses of Steroids in COVID-19 Patients
NCT05279482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104
Last updated 2022-03-15
Summary
aim of this study is to compare between standard dose methyl prednisolone and mega dose methyl prednisolone as regards outcome reflected by mortality rate, percentage of mechanically ventilated patients and icu length of stay of covid 19 patients admitted in intensive care unit.
Conditions
- Critical Illness
- Pneumonia, Viral
Interventions
- OTHER
-
observation for outcome of methylprednisolone dose
no intervention as it is retrospective study for outcome
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-19
- Primary Completion
- 2022-03-01
- Completion
- 2022-03-09
Countries
- Egypt
Study Locations
More Related Trials
-
Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
NCT04528888 ·Status: UNKNOWN ·Phase: PHASE3
-
Hydrocortisone for COVID-19 and Severe Hypoxia
NCT04348305 ·Status: COMPLETED ·Phase: PHASE3
-
Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome
NCT04492228 ·Status: UNKNOWN ·Phase: NA
-
Metformin and Lactoferrin in Sepsis in Icu
NCT06181422 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome
NCT04408326 ·Status: UNKNOWN
-
Evaluation of the Effect of Immune Modulating Enteral Nutrition Formula
NCT05186480 ·Status: UNKNOWN ·Phase: NA
-
Mitochondrial Function in Septic Patients
NCT03748537 ·Status: COMPLETED ·Phase: NA
-
Alpha-lipoic Acid in Critically Ill Patients With Sepsis
NCT06661993 ·Status: COMPLETED ·Phase: NA
-
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
NCT00368381 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Effect of Moderate-Dose Steroid Therapy in Sepsis
NCT01275638 ·Status: COMPLETED ·Phase: PHASE4
-
Triple Therapy in Septic Shock Patients
NCT04508946 ·Status: COMPLETED ·Phase: PHASE3
-
Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU
NCT04519762 ·Status: UNKNOWN ·Phase: PHASE4
-
Post-COVID-19 Mucormycosis in Critical Care
NCT05911035 ·Status: COMPLETED
-
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
NCT02213796 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Montelukast Versus Co Enzyme in Sepsis
NCT05293132 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19
NCT05195242 ·Status: COMPLETED ·Phase: PHASE3
-
Early Intravenous Hydrocortisone in Sepsis
NCT06217939 ·Status: RECRUITING ·Phase: NA
-
Initiation of Hydrocortisone for the Treatment of Septic Shock
NCT02580240 ·Status: COMPLETED ·Phase: NA
-
Intravenous Metoprolol in Septic Shock
NCT06592547 ·Status: COMPLETED ·Phase: PHASE2
-
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 ·Status: RECRUITING ·Phase: NA
-
Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.
NCT07200817 ·Status: RECRUITING
-
Convalescent Antibodies Infusion in COVID 19 Patients
NCT04418531 ·Status: WITHDRAWN ·Phase: NA
-
Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
NCT04402970 ·Status: COMPLETED ·Phase: PHASE3
-
Nebulised Heparin in Patients With COVID-19 Pneumonia
NCT05255848 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia
NCT05230472 ·Status: COMPLETED ·Phase: PHASE4